HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gait Apraxia

Impaired ambulation not attributed to sensory impairment or motor weakness. FRONTAL LOBE disorders; BASAL GANGLIA DISEASES (e.g., PARKINSONIAN DISORDERS); DEMENTIA, MULTI-INFARCT; ALZHEIMER DISEASE; and other conditions may be associated with gait apraxia.
Also Known As:
Bruns' Gait Apraxia; Frontal Gait Apraxia; Apraxia, Bruns' Gait; Apraxia, Frontal Gait; Apraxia, Gait; Apraxias, Bruns' Gait; Apraxias, Frontal Gait; Apraxias, Gait; Bruns Apraxia, Gait; Bruns Gait Apraxia; Bruns' Apraxia, Gait; Bruns' Gait Apraxias; Frontal Gait Apraxias; Gait Apraxia, Bruns'; Gait Apraxia, Frontal; Gait Apraxias; Gait Apraxias, Bruns'; Gait Apraxias, Frontal; Gait Dyspraxia; Gait Dyspraxias; Apraxia of Gait; Bruns' Apraxia of Gait; Dyspraxia of Gait
Networked: 11 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Parkinsonian Disorders (Parkinsonism)
2. Tremor (Tremors)
3. Pain (Aches)
4. Anorexia
5. Dementia (Dementias)

Experts

1. Annweiler, C: 3 articles (01/2015 - 12/2009)
2. Beauchet, O: 3 articles (01/2015 - 12/2009)
3. Bertolucci, Paulo Henrique Ferreira: 1 article (06/2016)
4. Oliveira, Fabricio Ferreira de: 1 article (06/2016)
5. Pereira, Fernando Vieira: 1 article (06/2016)
6. Schultz, Rodrigo Rizek: 1 article (06/2016)
7. Anderson-Mooney, Amelia J: 1 article (04/2016)
8. Head, Elizabeth: 1 article (04/2016)
9. Heilman, Kenneth M: 1 article (04/2016)
10. Lott, Ira T: 1 article (04/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Gait Apraxia:
1. Vitamin DFDA LinkGeneric
2. Therapeutic UsesIBA
3. Essential DrugsIBA
4. Generic DrugsIBA
5. Biomarkers (Surrogate Marker)IBA
6. Epirubicin (Ellence)FDA LinkGeneric
7. Psychotropic Drugs (Psychoactive Drugs)IBA
8. FlunarizineIBA
9. Ergocalciferols (Ergocalciferol)FDA LinkGeneric
10. Antidepressive Agents (Antidepressants)IBA

Therapies and Procedures

1. Therapeutics
2. Drug Substitution
3. Ventriculoperitoneal Shunt